only criteria. The clear persistence of the svmptoms suggests that functional hypoglvcaemia is a clinical condition. The general failure to show chemical hypoglycaemia, however, questions the use of the term functional hypoglyvcaemia and suggests a different explanation for the phenomenon. The glycaemic threshold for onset of hypoglycaemic symptoms and release of counterregulatory hormones might be higher than in normal subjects. Further studies should test this hypothesis.
Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study Objective-To establish whether a single preoperative dose of cefotaxime plus metronidazole was as effective as a standard three dose regimen of cefuroxime plus metronidazole in preventing wound infection after colorectal surgery.
Design-Prospective randomised allocation to one of two prophylactic antibiotic regimens in a parallel group trial. Group sequential analyses of each 250 patients were performed.
Setting-14 District general and teaching hospitals.
Patients-1018 Adults having colorectal operations were randomised, of whom 943 were evaluated. Demographic features, conditions requiring surgery, and operative procedures were similar in the two groups. Most patients had surgery for carcinoma of the colon or rectum.
Interventions-Group 1 received cefotaxime 1 g intravenously plus metronidazole 500 mg intravenously preoperatively. Group 2 received cefuroxime 1-5 g intravenously plus metronidazole 500 mg intravenously preoperatively, followed by cefuroxime 750 mg intravenously plus metronidazole 500 mg intravenously eight hours and 16 hours postoperatively.
Main outcome measures-Development of surgical wound infection (as evidenced by the presence of pus), death, or discharge from hospital.
Results-Wound condition was scored on a five point scale on alternate days until discharge or for up to 20 days postoperatively. Wound infection rates were: group 1, 32/453 (7.1%; 95% confidence interval 4-7% to 9.4%); group 2, 33/454 (7.3%; 95% confidence interval 4-9% to 9.6%). Death rates (group 1: 26/470 (5-5%); group 2: 31/471 (6.6%)), the incidence of postoperative complications, the median duration of hospital stay (12 days) , and antibiotic tolerance were all similar in the two groups. Pooled data from groups 1 and 2 showed that wound infections were more frequent when minor faecal contamination had occurred at operation and when the duration of operation exceeded 90 minutes (>90 min 11-2% of cases; <90 min 4-8%) and were associated with an extended hospital stay.
Conclusions-A single preoperative dose of cefotaxime plus metronidazole is as efficacious as a three dose regimen ofcefuroxime plus metronidazole in preventing wound infection after colorectal surgery and has practical advantages in eliminating the need for postoperative antibiotics.
Introduction
The use of antibiotics for prophylaxis against wound infection is well established in patients having operations on the gastrointestinal tract, particularly the large bowel, where the risk of infection from faecal micro-organisms is high.' 2 Despite acceptance of antibiotic prophylaxis in principle there is wide variation in the composition and duration of the antibiotic regimens employed.34 The ideal prophylactic regimen for large bowel surgery would exemplify activity against both aerobic and anaerobic bacteria with a consequent low incidence of wound infection, safety from unwanted drug effects, convenience of delivery, and low cost. A single preoperative dose of prophylactic antibiotics shown to be ofequal efficacy to a commonly used multiple dose regimen would satisfy these criteria. Though which two or more surgeons were participating in the trial these blocks of 10 were maintained intact for each surgeon in an attempt to minimise interoperator variation.
Trial antibiotics-Patients in group 1 received cefotaxime 1 g plus metronidazole 500 mg by intravenous infusion after induction of anaesthesia and five to 10 minutes before having their peritoneum opened. Patients in group 2 received an initial dose of cefuroxime 1 5 g plus metronidazole 500 mg by intravenous infusion after induction of anaesthesia and five to 10 minutes before having their peritoneum opened, followed by two further intravenous doses of cefuroxime 750 mg plus metronidazole 500 mg eight hours and 16 hours postoperatively.
Clinical evaluation-At operation the procedure performed and duration of surgery were recorded. Evaluable patients were observed for evidence of local or systemic adverse reactions to the antibiotics in addition to postoperative complications. Surgical wounds were examined and scored on a five point scale on alternate days beginning the day after the operation until discharge from hospital. The observer was unaware of the regimen used, and a wound was considered infected if the abdominal incision discharged pus. Perineal wounds, if present, were not evaluated. Inpatients were monitored until the day of discharge or the 20th day after operation. Any patient who died within 20 days after operation without developing an infection was excluded from analysis of wound infection rates and evaluated for antibiotic tolerance only. If, however, a patient died within 20 days after operation having shown evidence of wound infection he or she was included in analyses of both efficacy and tolerance. Patients were routinely reviewed as outpatients four to eight weeks after operation, when any further clinically important complications were recorded.
Microbiological evaluation-Swabs were taken from patients whose surgical wound drained pus and cultured aerobically and anaerobically. Identification of any organism cultured and testing for sensitivity to cefotaxime and cefuroxime were performed whenever possible.
Sample size and statistical methods-Published studies of colonic surgery in which systemic prophylaxis with cephalosporins was used have shown wound infection rates in the region of 10-15%.368'9 We decided to test for a 5% difference in infection rates between the two treatment groups with a 90% statistical power and 5% level of significance by using a group sequential analysis with predetermined inspection intervals.20 At the outset a triangular plot was constructed in which stopping boundaries for the trial were laid down. Interim analyses of wound infection rates were planned at inspection intervals of each 250 patients completing the trial-that is, after 250, 500, 750, 1000, and so on. At each point coordinates were to be plotted on the graph. The On stopping the trial the incidence of wound infection was almost identical in the two groups (table IV) . Infection rates of just over 7% were recorded, irrespective of which prophylactic regimen had been employed. The difference was not significant by X2 test with Yates's correction (X2<OOOl; P p>95) The 95% confidence intervals for wound infection rates were: group 1, 4-7% to 9 4%; group 2, 4-9% to 9 6%. Minor faecal contamination at operation was associated with a higher incidence of wound infection (40/389 patients; 10-3%) than absence of noticeable faecal contamination (25/517; 488%) (x2=9 1; p<003). There was a slight but non-significant association between wound infection and obesity; patients with body mass index of >24 had a wound infection rate of 8-8% compared with a rate of 6 5% among those with a body mass index of <24.
More prolonged operations resulted in a higher incidence of infection (table V) . Logistic regression showed that operations lasting less than and longer than 90 minutes were associated with wound infection rates of 488% and 11-2% respectively (x2=-1315; p<003). There was no significant difference between the treatment groups or in the interaction of treatment with the duration of surgery. Similarly, there was a significant relation between infection rate and length of hospital stay. Logistic regression showed that the incidence of wound infection increased at the same rate for each treatment group-from 2-2% in patients staying less than 15 days to 13 5% in patients staying 15 days or more (X =33 1; p<0001).
When we set aside the few patients with ischaemic bowel disease and bowel stricture (see table VI) it seemed that rectal carcinoma, bowel obstruction, and diverticular disease were associated with higher incidences of wound infection whereas patients with inflammatory bowel disease had a comparatively low incidence of infection. Similarly, certain procedures (Hartmann's procedure, abdominoperineal resection) seemed to carry higher risks of infection (table VII) . Left hemicolectomy had a higher infection rate than did right hemicolectomy. The data in tables VI and VII are not amenable to statistical analyses. ADVERSE 
EVENTS
Seven (074%) adverse events were reported among the 943 evaluable patients. In only two of these was a relation between the event and the antibiotic suspected. One patient allocated to receive three dose cefuroxime plus metronidazole suffered a coagulation disorder eight hours postoperatively followed by fatal haemorrhage four hours later. In the cefotaxime plus metronidazole group one patient who had a ring pessary in situ before operation developed perineal and vaginal candidiasis. No case of pseudomembranous colitis was reported in either group.
Discussion
This study has shown with a high degree of statistical power that a single preoperative dose of cefotaxime plus metronidazole is of equal efficacy to a standard Wound infection rates were rather lower than had been expected at the outset based on published trials in similar series of patients.68 9 Plainly the incidence of infection is directly related to the definition used (in this case the presence of pus at the abdominal wound site). Nevertheless, had a stricter definition been used-for example, including both positive bacteriological results and pus-then the rate would have been lower still.
The incidence of possibly drug related adverse events was low in both groups, though one coagulation disorder followed by haemorrhage occurred with cefuroxime plus metronidazole. Coagulation disorders BMJ VOLUME 300 6 JANUARY 1990 which may lead to serious postoperative bleeding are more commonly associated with certain cephalosporins having the N-methylthiotetrazole side chain-' but have been noted with others -such as cefuroxime -lacking this side chain. In a six week survey of 136 beds a pharmacist examined patient records for adverse reactions and collected reports from nurses and prescribers who had been circulated with guidelines on reporting drug side effects. Thirty eight reactions were detected among 706 patients (5 4%), most (21) from patient records; eight were reported by nurses but only three by prescribers (the rest came from a combination of sources).
We then offered IR£3 to junior doctors for each completed yellow card given to a designated registrar. Within six weeks 150 reports had been received (an incidence of9 7%). These included two drug associated deaths (streptokinase anaphylaxis, pentamidine pancreatitis) and 27 serious or life threatening' reactions -for example, bone marrow suppression, arrhythmias, gastrointestinal haemorrhage, warfarin interaction, pseudomembranous colitis, hepatotoxicity, and the
